OR WAIT 15 SECS
© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
© 2020 MJH Life Sciences™ and Drug Topics. All rights reserved.
November 27, 2020
A recent study showed “alarming” rates of reported loneliness, anxiety, depression, and substance use in young adults during COVID-19.
The pharmaceutical company has submitted a New Drug Application for dihydroergotamine mesylate for fast and lasting whole migraine relief in adults with and without aura.
November 26, 2020
A study to be presented at the annual meeting of the Radiological Society of North America reported that COVID-19 patients with diabetes and hypertension may have a higher risk for neurologic complications.
November 23, 2020
Baloxavir marboxil (Xofluza; Genentech) is the first single-dose influenza medicine approved for post-exposure prophylaxis.